Featured Research

from universities, journals, and other organizations

Scientists Discover Receptor Involved In Forming Valves And Walls In Heart

Date:
March 29, 1999
Source:
Vanderbilt University Medical Center
Summary:
Vanderbilt University Medical Center scientists deciphered how the Type III TGF-beta receptor leads to the formation of valves and dividing walls in the heart, reports the March 26th issue of Science.

Vanderbilt University Medical Center scientists deciphered how the Type III TGF-beta receptor leads to the formation of valves and dividing walls in the heart, reports the March 26th issue of Science.

Their findings have particular relevance to the families of children with congenital heart defects, the leading cause of birth defect-related deaths. About 1 in 100 children born each year in the United States have heart defects, yet little is known about the causes, and surgery is often the only treatment option.

Joey V. Barnett, Ph.D., assistant professor of Medicine and Pharmacology and a member of the division of Cardiovascular Medicine, is interested in the role of growth factors in heart development, particularly how the valves and septa-dividing walls-of the heart are formed.

Their formation begins when the heart is only a simple tube and cells in a region called the atrioventricular (AV) cushion receive a signal that tells them to change shape, pull away from their neighbors and migrate. Those cells eventually multiply and give rise to the heart's valves and septa.

It has been a mystery why only a small population of cells receives the signal to change.

"Their neighbors never undergo this epithelial-mesenchymal transformation," Barnett said. "We wanted to know why, so we asked what cell surface receptors are found on the cells that transform but are missing on the cells that do not."

Transforming growth factor-beta (TGF-beta) has been suspected to play a role in transformation of the AV cushion cells, so Barnett and Christopher B. Brown, Ph.D. focused on the different types of TGF-beta receptors.

In the current report, they show that the Type III TGF-beta receptor is found on those cells in the developing heart that undergo the transformation.

"If we use experimental techniques in an in vitro assay to block this receptor on those cells, they don't transform," Barnett said. "Conversely, if we introduce this receptor into cells that normally would not respond-the neighbor cells, they do transform in response to TGF-beta."

The findings provide strong evidence that the Type III TGF-beta receptor is essential for AV cushion cell response and transformation.

Non-functional Type III TGF-beta receptor might cause some types of congenital heart defects. In fact, many affected children have defects in valves or septa that can be explained by failure of the AV cushion cells to transform and migrate.

Recently, these defects have been associated with damage to a region of chromosome 1 that includes the gene for the Type III TGF-beta receptor. Several groups are working hard to identify mutations in this receptor, Barnett said.

The Type III TGF-beta receptor has been something of a mystery. A complex of Type I and Type II TGF-beta receptors mediates the well-characterized effects of the growth factor TGF-beta on cell growth and differentiation. The Type III TGF-beta receptor is not capable of sending a signal into the cell by itself and was considered to be a facilitator of the Type I/II complex.

"The Type III receptor was the first TGF-beta receptor cloned, but we've been unable to assign a specific biological function for it," Barnett said. "It's remained an orphan in that regard."

The newly defined role for the Type III TGF-beta receptor in AV cushion transformation during heart development sparks questions about how this receptor sends signals.

"Our data suggest that the Type III TGF-beta receptor does more than facilitate transmission through the Type I/II receptor complex," Barnett said. "It looks like it must be using another signaling pathway that is independent of the other two receptor types."

The possibility of a new way for TGF-beta to send signals opens up a whole new area for research into this growth factor's actions.

These studies were supported by grants from the NIH, American Heart Association, and March of Dimes.


Story Source:

The above story is based on materials provided by Vanderbilt University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Vanderbilt University Medical Center. "Scientists Discover Receptor Involved In Forming Valves And Walls In Heart." ScienceDaily. ScienceDaily, 29 March 1999. <www.sciencedaily.com/releases/1999/03/990323111131.htm>.
Vanderbilt University Medical Center. (1999, March 29). Scientists Discover Receptor Involved In Forming Valves And Walls In Heart. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/1999/03/990323111131.htm
Vanderbilt University Medical Center. "Scientists Discover Receptor Involved In Forming Valves And Walls In Heart." ScienceDaily. www.sciencedaily.com/releases/1999/03/990323111131.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins